Current Diagnosis, Treatment and Etiology of Status Epilepticus
PDF
Cite
Share
Request
Review
VOLUME: 20 ISSUE: 1
P: 1 - 10
April 2014

Current Diagnosis, Treatment and Etiology of Status Epilepticus

Arch Epilepsy 2014;20(1):1-10
1. Department Of Neurology, Vezirköprü State Hospital, Samsun
2. Department Of Neurology, Ondokuz Mayıs University Faculty Of Medicine, Samsun
No information available.
No information available
Received Date: 09.09.2013
Accepted Date: 11.01.2014
PDF
Cite
Share
Request

ABSTRACT

Status Epilepticus (SE) is a medical emergency that causes significant morbidity and mortality and requires prompt diagnosis and treatment. Although SE can be divided into two subgroups as convulsive and nonconvulsive, treatment principles are generally similar. Treatment should be prompt and underlying cause should be corrected. Although intravenous lorazepam is the first-line treatment due to a lower risk of relapse, diazepam becomes the first choice since loeazepan is not available in our country. Even though intravenous benzodiazepine stops seizures, intravenous antiepileptic drug (phenytoin, etc.) should be administered at a loading dose. Patients with refractory status epilepticus should be supported with respect to vital, respiratory, metabolic and hemodynamic aspects and followed up in an intensive care unit to monitor cerebral electrical activity. The most common cause in the etiology is the cessation of antiepileptic drugs. The aim of SE treatment is to stop seizures and prevent complications and recurrence. In this paper, current diagnosis, treatment and etiology of SE are reviewed.

Keywords:
Aetiology, status epileptikus, diagnosis, treatment